A detailed history of American Research & Management Co. transactions in Dexcom Inc stock. As of the latest transaction made, American Research & Management Co. holds 687 shares of DXCM stock, worth $54,554. This represents 0.02% of its overall portfolio holdings.

Number of Shares
687
Previous 640 7.34%
Holding current value
$54,554
Previous $48,000 14.58%
% of portfolio
0.02%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 07, 2022

BUY
$76.35 - $94.18 $3,588 - $4,426
47 Added 7.34%
687 $55,000
Q2 2022

Jul 22, 2022

BUY
$67.99 - $132.89 $32,635 - $63,787
480 Added 300.0%
640 $48,000
Q3 2021

Oct 28, 2021

SELL
$106.71 - $143.18 $3,201 - $4,295
-30 Reduced 15.79%
160 $87,000
Q1 2019

Apr 16, 2019

BUY
$28.07 - $38.18 $2,526 - $3,436
90 Added 90.0%
190 $23,000
Q2 2018

Jul 25, 2018

SELL
$17.54 - $25.22 $1,754 - $2,522
-100 Reduced 50.0%
100 $9,000
Q3 2017

Oct 17, 2017

BUY
$11.36 - $18.98 $2,272 - $3,796
200
200 $10,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track American Research & Management Co. Portfolio

Follow American Research & Management Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.